Akebia therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Akebia therapeutics Contact Number

Connect Akebia Therapeutics

7 hours ago Akebia.com Show details

617.871.2098

Akebia Therapeutics, Inc. 245 First Street, Suite 1400. Cambridge, MA 02142 +1 617.871.2098 phone +1 617.871.2099 fax. For all general inquiries, please contact:

Category: Contact NumberShow more

Home Akebia Therapeutics

9 hours ago Akebia.com Show details

You are leaving akebia.com, a website of Akebia Therapeutics, Inc. Akebia does not review or control the content of non-Akebia websites, and this hyperlink does not constitute an endorsement by Akebia of the site’s content. Akebia’s privacy procedures do not apply to the owners of a non-Akebia website.

Category: Home PhoneShow more

Akebia Therapeutics Crunchbase Company Profile & Funding

9 hours ago Crunchbase.com Show details

(617) 871-2098

Legal Name Akebia Therapeutics Inc. Stock Symbol NASDAQ:AKBA. Company Type For Profit. Contact Email [email protected]akebia.com. Phone Number (617) 871-2098. Akebia Therapeutics, Inc., a pharmaceutical company, focuses on treatments for ischemia and improvement of vascular disease. It engages in the clinical development of compounds for the treatment of

Founded: 2007
Founders: Dr Joseph Gardner, Robert Shalwitz

Category: Contact NumberShow more

Contact IR Akebia Therapeutics

8 hours ago Ir.akebia.com Show details

The Investor Relations website contains information about Akebia Therapeutics's business for stockholders, potential investors, and financial analysts.

Category: Contact SupportShow more

Employment Verification for Akebia Therapeutics Inc Truework

7 hours ago Truework.com Show details

The information on this page is not an endorsement of Truework's services by Akebia Therapeutics Inc and is meant to be purely informational. number of employees <100. category Biotechnology. address 245 First St, Cambridge, MA 02142, USA. links Akebia Therapeutics Inc Website. Contact

Category: Contact NumberShow more

AURYXIA Our Assistance Programs

3 hours ago Auryxia.com Show details

855-686-8601

Contact an AkebiaCares Case Manager Certain qualified patients or patients with an income up to 400% of the Federal Poverty Level (FPL) may be eligible for additional assistance through AkebiaCares. If you're unsure about your patient's eligibility status, be sure to reach out to your AkebiaCares Case Manager for help at 855-686-8601 .

Category: Contact NumberShow more

About Akebia Therapeutics

5 hours ago Akebia.com Show details

About - Akebia Therapeutics. Management / Board of Directors. Our team is bold and optimistic. Since our founding in 2007, we’ve put tenacity and innovation to work to develop unique therapeutics that have the potential to set new standards of care for people living with kidney disease. We have emerged as a leader with deep roots in the renal

Category: Contact NumberShow more

AURYXIA AkebiaCares

6 hours ago Auryxia.com Show details

The most common adverse reactions reported with AURYXIA in clinical trials were: Hyperphosphatemia in CKD on Dialysis: Diarrhea (21%), discolored feces (19%), nausea (11%), constipation (8%), vomiting (7%) and cough (6%) Iron Deficiency Anemia in CKD Not on Dialysis: Discolored feces (22%), diarrhea (21%), constipation (18%), nausea (10%

Category: Contact NumberShow more

Akebia – Specialty Pharmacy Locator

2 hours ago Akebia.aspnprograms.com Show details

Akebia does not receive payment for this service and does not own, operate, or control any specialty pharmacy. Inclusion in this database does not represent an endorsement of, recommendation for, or referral to, the specialty pharmacies listed in this database by Akebia Therapeutics, Inc.

Category: Contact NumberShow more

Keryx Biopharmaceuticals Crunchbase Company Profile

4 hours ago Crunchbase.com Show details

212-531-5965

Contact Email [email protected] Phone Number +1 212-531-5965. Keryx Biopharmaceuticals is a biopharmaceutical company that is focused on the development and commercialization of medicines for chronic kidney diseases. Keryx Biopharmaceuticals offers Auryxia, a medicine that is able to lower the amount of phosphate in blood.

Category: Contact NumberShow more

Integrity Matters Akebia Therapeutics

1 hours ago Ir.akebia.com Show details

Akebia’s reputation, attract talented employees and preserve a culture where integrity matters. Thank you for your commitment to Akebia and to doing things the right way. John P. Butler President and Chief Executive Officer Akebia Therapeutics, Inc. Code of Conduct 3

Category: Contact NumberShow more

Partnering Akebia Therapeutics

Just Now Akebia.com Show details

If interested in partnering with Akebia, please contact: [email protected]. Current Partnerships. Otsuka Pharmaceutical Company . In 2016, Akebia entered into a collaboration and license agreement with Otsuka Pharmaceutical Company (Otsuka) for development and commercialization of vadadustat in the U.S. Under the terms of the agreement, the

Category: Contact NumberShow more

11509424 AkebiaCares Enrollment Form TIPS M6FR.indd 1 …

9 hours ago Auryxia.com Show details

AKEBIA THERAPEUTICS AKEBIA-AURYXIA CKD PP-AUR-US-0907 9290282 Native Packaged File 8.5"w X 11"h Trim None Security Number (SSN), please write "N/A" (optional): By checking this box, I authorize Akebia, and companies working with Akebia, to contact me regarding product and educational information, and for other opportunities, such as for

Category: Contact NumberShow more

Akebia Therapeutics Home Facebook

4 hours ago Facebook.com Show details

Akebia Therapeutics. May 14 at 8:46 AM ·. We love teal, clearly! One of our Akebians found this clutch of robin eggs hanging in her planter. Fun fact about bird eggs that are blue or green – the pigmentation has been found through research to allow the egg to absorb the perfect amount of solar energy which keeps the egg warm.

Category: Home PhoneShow more

Enrollment Form for AURYXIA (ferric citrate)

4 hours ago Auryxia.com Show details

©2021 Akebia Therapeutics, Inc. PP-AUR-US-1361 (v2.0) 06/21 *Akebia has the right to require written proof of income (such as a Form 1040, Form W-2, or other documentation) from patients in connection with a financial eligibility

Category: Contact NumberShow more

Privacy Policy Akebia Therapeutics

4 hours ago Akebia.com Show details

617-871-2098

Akebia Therapeutics, Inc. 245 First Street, Suite 1400. Cambridge, MA 02142. +1 617-871-2098. +1 617-871-2099 (fax) However, if you are in the EEA or UK and wish to exercise any of the privacy rights described under “ Users in the European Economic Area and the United Kingdom ,” please contact [email protected]akebia.com.

Category: Contact NumberShow more

Contact Us Akari Therapeutics

5 hours ago Akaritx.com Show details

20-8004-0261

Until more data are available, Akari Therapeutics is not considering requests for expanded access outside of clinical trials. This policy may change as safety and efficacy are better demonstrated. For questions regarding our current expanded access policy, please contact Akari Therapeutics at +44 (0)20-8004-0261.

Category: Contact SupportShow more

Akebia Therapeutics, Inc. (Form: DEFA14A, Received: 05/21

6 hours ago Content.edgar-online.com Show details

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release. Contact

Category: Contact NumberShow more

Akebia Therapeutics, Inc. (AKBA) Company Profile & Facts

4 hours ago Finance.yahoo.com Show details

See the company profile for Akebia Therapeutics, Inc. (AKBA) including business summary, industry/sector information, number of employees, business summary, corporate governance, key …

Category: Contact NumberShow more

Akebia Reports First Quarter 2021 Akebia Therapeutics

2 hours ago Ir.akebia.com Show details

CAMBRIDGE, Mass., May 10, 2021 /PRNewswire/ -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, today reported financial results for the first quarter ended March 31, 2021 and highlighted recent corporate milestones. The Company will host a conference call today, Monday, …

Category: Contact NumberShow more

United States Court of Appeals

9 hours ago Media.ca1.uscourts.gov Show details

lowest number provided for each individual or position's hourly-rate range. The district court denied the following requests: • Expenses incurred before June 8, 2016 because Akebia had no contact with the DOJ before then. • Certain entries for attorney and non-attorney time deemed insufficiently explained.

Category: Contact NumberShow more

Akebia Reports Second Quarter 2020 Financial Results

9 hours ago Ir.akebia.com Show details

844-445-3799

Akebia Therapeutics, Inc. (Nasdaq: To report suspected adverse reactions, contact Akebia Therapeutics at 1-844-445-3799. Please see full Prescribing Information. Forward-Looking Statements Weighted-average number of common shares - …

Category: Contact NumberShow more

AKEBIA THERAPEUTICS, INC. : Shareholders Board Members

4 hours ago Marketscreener.com Show details

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Company's lead product candidate, vadadustat, is indicated for the …

Category: Contact NumberShow more

Akebia Therapeutics Reports Second Quarter 2021 Financial

4 hours ago Ir.akebia.com Show details

CAMBRIDGE, Mass., Aug. 5, 2021 /PRNewswire/ -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, today reported financial results for the second quarter ended June 30, 2021 and highlighted recent corporate milestones. The Company will host a conference call today, Thursday, …

Category: Contact NumberShow more

Akebia Therapeutics, Inc. – Schall Law Firm

3 hours ago Schallfirm.com Show details

Akebia Therapeutics, Inc. Join Class Action » The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Akebia Therapeutics, Inc. (“Akebia” or “the Company”) (NASDAQ: AKBA) who formerly held shares of Keryx Biopharmaceuticals, Inc. (KERX) for violations of the securities laws.

Category: Contact NumberShow more

Akebia Therapeutics Reviews Glassdoor

3 hours ago Glassdoor.com Show details

If you’re comfortable, I’d welcome you to contact your People Business Partner, me directly, or your manager so that we better understand your challenges and work together to address them. Our goal is to make Akebia a place that everyone …

Category: Contact NumberShow more

What Type Of Shareholders Own The Most Number of Akebia

9 hours ago Finance.yahoo.com Show details

Hedge funds don't have many shares in Akebia Therapeutics. Looking at our data, we can see that the largest shareholder is State Street Global Advisors, Inc. with 15% of …

Category: Contact NumberShow more

Akebia Reports First Quarter 2021 Financial Results and

9 hours ago Finance.yahoo.com Show details

(855) 859-2056

To access the replay, dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and reference conference ID number 6250159. contact Akebia Therapeutics at 1-844-445-3799.

Category: Contact NumberShow more

Akebia Therapeutics Number of Employees 20132021 AKBA

6 hours ago Macrotrends.net Show details

Akebia Therapeutics number of employees from 2013 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Akebia Therapeutics Inc. is a biopharmaceutical company.

Category: Contact NumberShow more

Companies with 'A' EIN, Address and Contact Page 1

6 hours ago Eintaxid.com Show details

(646) 350-0702

EIN Number: 98-1034922 Address: 24 West 40th Street, 8th Floor, New York, New York Doing Business As: Akari Therapeutics Plc Phone: (646) 350-0702

Category: Contact SupportShow more

Associate Director Development Finance Job in Cambridge

1 hours ago Ziprecruiter.com Show details

Associate Director Development Finance. Nearly 37 million Americans are currently affected by Chronic Kidney Disease. 37 million. At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person impacted by kidney disease and the renal community that serves them.

Category: Contact NumberShow more

Working at Akebia Therapeutics Glassdoor

7 hours ago Glassdoor.com Show details

Mission: Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts.

Category: Contact NumberShow more

Smith Drug Company

5 hours ago Smithdrug.com Show details

(617) 466-3452

Akebia Therapeutics 245 First Street I Cambridge, MA 02142 Office: (617) 466-3452 Mobile: (857) 777-6584 mshea akebia.com GMB-SPS-ReturnRe uests cordlo istics.com or 614-652-0271 Customer Information: Account Name: Contact Phone Number: Address: Debit/ Reference Number: Wholesaler City & State: (Please check the appropriate box) Contact

Category: Contact NumberShow more

Andrew Spaziani Greater Denver Area Professional

1 hours ago Linkedin.com Show details

Contact Andrew directly Director, Clinical Account Manager at Acer Therapeutics Inc. Alpharetta, GA. Matt Seibt. Matt Seibt Sales Training & Development at Akebia Therapeutics Doylestown, PA.

1. 500+ connections
Location: Greater Denver

Category: Contact NumberShow more

Patents Akebia Therapeutics Inc v Fibrogen, Inc,

5 hours ago Nipclaw.blogspot.com Show details

Patents Court (Lord Justice Arnold) Akebia Therapeutics Inc v Fibrogen, Inc [2020] EWHC 866 (Pat) (20 April 2020) This was a claim by Akebia Therapeutics Inc. (“Akebia”) and Otsuka Pharmaceutical Co. Ltd. (“Otsuka”) to revoke 6 patents held by FibroGen Inc. ("FibroGen"). The reason why they sought the revocation of those patents is that

Category: Contact NumberShow more

Akebia Therapeutics Reports Second Quarter 2021 Financial

8 hours ago Finance.yahoo.com Show details

(855) 859-2056

To access the replay, dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and reference conference ID number 5529396. contact Akebia Therapeutics at 1-844-445-3799.

Category: Contact NumberShow more

Director Regulatory CMC (Cambridge or Remote position

1 hours ago Ziprecruiter.com Show details

At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person impacted by kidney disease and the renal community that serves them. Our tenacious, passionate employees challenge the status quo and work to develop unique therapeutics that have the potential to set new standards

Category: Contact NumberShow more

Anupam Dalal Managing Director @ Kearny Venture Partners

6 hours ago Crunchbase.com Show details

Anupam is a board member of Aerpio Therapeutics and Akebia Therapeutics. He led Kearny's investment in Nextwave Pharmaceuticals. At Flagship, he was a board member with Resolvyx Pharmaceuticals and Pervasis (acquired by Shire) and an observer at. CGI Pharmaceuticals (acquired by Gilead), Adnexus Therapeutics (acquired by Bristol-Myers Squibb

Category: Contact NumberShow more

Akebia Therapeutics Announces September 2021 Investor

Just Now Finance.yahoo.com Show details

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The …

Category: Contact NumberShow more

Director, Supplier Risk Management (Cambridge MA or Remote

5 hours ago Ziprecruiter.com Show details

At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person impacted by kidney disease and the renal community that serves them. Our tenacious, passionate employees challenge the status quo and work to develop unique therapeutics that have the potential to set new standards

Category: Contact NumberShow more

Laura Olejnik RD's email & phone number Training Manager

1 hours ago Signalhire.com Show details

View Laura Olejnik RD's email address: [email protected]akebia.com & phone: +1-520-xxx-xx53's profile as Training Manager at Akebia Therapeutics, located in Greater Chicago Area. Find contacts: direct phone number, email address, work experience.

Category: Phone NumberShow more

Executive Assistant Job in Cambridge, MA at Akebia

2 hours ago Ziprecruiter.com Show details

At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person impacted by kidney disease and the renal community that serves them. Our tenacious, passionate employees challenge the status quo and work to develop unique therapeutics that have the potential to set new standards

Category: Contact NumberShow more

Akero Therapeutics Efruxifermin (EFX) for NASH Contact

8 hours ago Akerotx.com Show details

(650) 487-6488

Akero Therapeutics. 601 Gateway Boulevard, Suite 350 South San Francisco, CA 94080 (650) 487-6488

Category: Contact SupportShow more

Hui Fang Director of Product Quality Attributes and

5 hours ago Linkedin.com Show details

Participate in CMC development of a number of projects at pre-clinical, phase I, phase II, and post-marketing stage (Halaven); Contact Hui directly Scientist II at Akebia Therapeutics

Title: Director of Product Quality …
Location: Andover, Massachusetts, United States
1. 500+ connections

Category: Contact NumberShow more

American Society of Nephrology Kidney Week Abstract

2 hours ago Asn-online.org Show details

202-640-4660

Contact ASN. 1401 H St, NW, Ste 900, Washington, DC 20005. [email protected] 202-640-4660

Category: Contact NumberShow more

AURYXIA Disease 101

7 hours ago Auryxia.com Show details

AURYXIA is a prescription medicine that can lower the amount of phosphate in the blood for adults with chronic kidney disease (CKD) who ARE on dialysis. For adults who have iron deficiency anemia, as well as CKD, and are NOT on dialysis, AURYXIA is a prescription medicine that can increase hemoglobin levels and increase iron levels in the body.

Category: Contact NumberShow more

AKEBIA THERAPEUTICS, INC. : Other Events (form 8K

6 hours ago Marketscreener.com Show details

Item 8.01 Other Events. On September 22, 2021, Keryx Biopharmaceuticals, Inc. ("Keryx"), a wholly owned subsidiary of Akebia Therapeutics, Inc., and its licensors, Panion & BF Biotech, Inc. ("Panion") and Chen Hsing Hsu, M.D. ("Dr. Hsu") entered into a settlement and license agreement (the "Agreement") with Mylan Pharmaceuticals Inc. ("Mylan"). This settlement resolves …

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What is the purpose of akebia therapeutics company?

At Akebia, we are all in on our purpose – to better the life of each person impacted by kidney disease. We know that big change is possible when we work together, within Akebia and well beyond our four walls.

Where is the registered office of akari therapeutics?

For business development inquiries: [email protected] REGISTERED ADDRESS Akari Therapeutics, Plc is registered in England and Wales under number 5252842 and has its registered office at Highdown House, Yeoman Way, Worthing, West Sussex, BN99 3HH.

How to contact akebiacares for enrollment in auryxia?

*If you have any questions about an enrollment form after it has been submitted to AkebiaCares, please call 855-686-8601. † Depending on which indication AURYXIA was prescribed for.

Brand New Updated

Popular Brands

Amazon
Abbvie
Aia
Asml
Apple
Att
Amgen
Adobe
Aptar
Acc
Adidas
Aak
Aes
Asx